Braveheart Bio, Inc.

BRVE chart

Braveheart Bio, Inc. news

• Braveheart Bio (NASDAQ:BRVE) Shares Gap Up - Here's Why

  MarketBeat · Oct 22, 12:07 PM EDT

• Braveheart Bio (NASDAQ:BRVE) Stock Keeps Overweight Rating at Cantor Fitzgerald

  MarketBeat · Oct 22, 3:00 AM EDT

• Braveheart Bio to Participate in Stifel Cardiometabolic Forum

  Yahoo Finance · Sep 16, 4:30 PM EDT

• Braveheart Bio Reports Second Quarter 2026 Financial Results and Provides Business Update

  Yahoo Finance · Sep 8, 4:03 PM EDT

• The Market Barely Knows These 2 IPO Stocks — Goldman Sachs Says ‘Buy’

  Yahoo Finance · Sep 8, 2:01 PM EDT

• Braveheart Bio to Participate in Cantor Global Healthcare Conference

  Yahoo Finance · Sep 1, 4:30 PM EDT

• Insiders Are Betting Big on These 3 Healthcare Stocks

  insidertrades.com · Aug 31, 1:20 PM EDT

• Deere upgraded, Lumentum initiated: Wall Street's top analyst calls

  Yahoo Finance · Aug 31, 9:45 AM EDT

• Jefferies starts biopharma firm Braveheart at Buy after IPO

  Yahoo Finance · Aug 31, 7:00 AM EDT

• Braveheart Bio (BRVE) Raised $382.5 Million In Its IPO

  Yahoo Finance · Aug 11, 4:08 PM EDT

• Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

  Yahoo Finance · Aug 7, 4:05 PM EDT

• Braveheart Bio Announces Pricing of Upsized Initial Public Offering

  Yahoo Finance · Aug 5, 10:33 PM EDT

Braveheart Bio, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-09-08
• 8-K8-K2026-09-08
• 8-K8-K2026-08-07
• S-1S-12026-07-15

About Braveheart Bio, Inc.

Ticker

BRVE (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

San Francisco, CA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

2131524

Frequently asked questions